3-Aminobenzamide prevents restraint-evoked immunocompromise

Brain, Behavior, and Immunity

Volumn 19, Issue 4, 2005, Pages 351-356

  Neigh, Gretchen N ^a,b   Samuelsson, Andrew R ^a   Bowers, Stephanie L ^a   Nelson, Randy J ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Immune; KLH; PARP; Restraint; Stress

Indexed keywords

3 AMINOBENZAMIDE; ANTIBODY; CORTICOSTERONE; IMMUNOGLOBULIN G ANTIBODY; KEYHOLE LIMPET HEMOCYANIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR;

ACTIVE IMMUNIZATION; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ARTICLE; BODY MASS; CONTROLLED STUDY; DOSE RESPONSE; HABITUATION; HUMORAL IMMUNE DEFICIENCY; IMMOBILIZATION STRESS; IMMUNOGLOBULIN PRODUCTION; IMMUNOSTIMULATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANALYSIS OF VARIANCE; ANIMALS; ANTIBODY FORMATION; BENZAMIDES; CORTICOSTERONE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; HABITUATION, PSYCHOPHYSIOLOGIC; HEMOCYANIN; MALE; MICE; MICE, INBRED C57BL; POLY(ADP-RIBOSE) POLYMERASES; RANDOM ALLOCATION; RESTRAINT, PHYSICAL; STRESS, PSYCHOLOGICAL;

EID: 20444428725     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbi.2004.11.001     Document Type: Article

References (32)

1. B.C. Amick 3rd, P. McDonough, H. Chang, W.H. Rogers, C.F. Pieper, and G. Duncan Relationship between all-cause mortality and cumulative working life course psychosocial and physical exposures in the United States labor market from 1968 to 1992 Psychosom. Med. 64 2002 370 381
2. E.H. Austin, M.F. Brennan, and S.A. Rosenberg Effects of protein-calorie restriction on the immune response to skin allografts in the rat Transplantation 30 1980 219 225
3. E.G. Balbin, G.H. Ironson, and G.F. Solomon Stress and coping: the psychoneuroimmunology of HIV/AIDS Baillieres Best Pract. Res. Clin. Endocrinol. Metab. 13 1999 615 633
4. M.E. Bauer, P. Perks, S.L. Lightman, and N. Shanks Restraint stress is associated with changes in glucocorticoid immunoregulation Physiol. Behav. 73 2001 525 532
5. J. Bowes, and C. Thiemermann Effects of inhibitors of the activity of poly (ADP-ribose) synthetase on the liver injury caused by ischaemia- reperfusion: a comparison with radical scavengers Br. J. Pharmacol. 124 1998 1254 1260
6. A. Chiarugi Inhibitors of poly(ADP-ribose) polymerase-1 suppress transcriptional activation in lymphocytes and ameliorate autoimmune encephalomyelitis in rats Br. J. Pharmacol. 137 2002 761 770
7. G.P. Chrousos The role of stress and the hypothalamic-pituitary-adrenal axis in the pathogenesis of the metabolic syndrome: neuro-endocrine and target tissue-related causes Int. J. Obes. Relat. Metab. Disord. 24 Suppl. 2 2000 S50 55
8. G.P. Chrousos Stress, chronic inflammation, and emotional and physical well-being: concurrent effects and chronic sequelae J. Allergy Clin. Immunol. 106 2000 S275 S291
9. J.Y. Couturier, L. Ding-Zhou, N. Croci, M. Plotkine, and I. Margaill 3-Aminobenzamide reduces brain infarction and neutrophil infiltration after transient focal cerebral ischemia in mice Exp. Neurol. 184 2003 973 980
10. F.S. Dhabhar, and B.S. McEwen Enhancing versus suppressive effects of stress hormones on skin immune function Proc. Natl. Acad. Sci. USA 96 1999 1059 1064
11. F.J. Dixon, H. Jacot-Guillarmod, and P.J. McConahey The antibody responses of rabbits and rats to hemocyanin J. Immunol. 97 1966 350 355
12. D.L. Drazen, D. Bilu, N. Edwards, and R.J. Nelson Disruption of poly (ADP-ribose) polymerase (PARP) protects against stress-evoked immunocompromise Mol. Med. 7 2001 761 766
13. D. Dreau, D.S. Morton, M. Foster, N. Fowler, and G. Sonnenfeld Effects of 2-deoxy-d-glucose administration on immune parameters in mice Immunopharmacology 39 1998 201 213
14. H.C. Ha, and S.H. Snyder Poly(ADP-ribose) polymerase-1 in the nervous system Neurobiol. Dis. 7 2000 225 239
15. M. Irie, S. Asami, S. Nagata, M. Miyata, and H. Kasai Relationships between perceived workload, stress and oxidative DNA damage Int. Arch. Occup. Environ. Health 74 2001 153 157
16. G. Keppel Design and Analysis 1991 Prentice Hall Upper Saddle River, New Jersey
17. G.M. Lord, G. Matarese, J.K. Howard, R.J. Baker, S.R. Bloom, and R.I. Lechler Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression Nature 394 1998 897 901
18. J.G. Mabley, P. Jagtap, M. Perretti, S.J. Getting, A.L. Salzman, L. Virag, E. Szabo, F.G. Soriano, L. Liaudet, G.E. Abdelkarim, G. Hasko, A. Marton, G.J. Southan, and C. Szabo Anti-inflammatory effects of a novel, potent inhibitor of poly (ADP-ribose) polymerase Inflamm. Res. 50 2001 561 569
19. M.C. McDonald, H. Mota-Filipe, J.A. Wright, M. Abdelrahman, M.D. Threadgill, A.S. Thompson, and C. Thiemermann Effects of 5-aminoisoquinolinone, a water-soluble, potent inhibitor of the activity of poly (ADP-ribose) polymerase on the organ injury and dysfunction caused by haemorrhagic shock Br. J. Pharmacol. 130 2000 843 850
20. G.N. Neigh, S.D. Bilbo, A.K. Hotchkiss, and R.J. Nelson Pyruvate supplementation prevents stress-evoked suppression of mitogen-stimulated proliferation Brain. Behav. Immun. 18 2004 425 433
21. G.N. Neigh, S.L. Bowers, L.M. Pyter, M.L. Gatien, and R.J. Nelson Pyruvate prevents restraint-induced immunosuppression via alterations in glucocorticoid responses Endocrinology 145 2004 4309 4319
22. A. Ozdulger, I. Cinel, A. Unlu, L. Cinel, I. Mavioglu, L. Tamer, U. Atik, and U. Oral Poly(Adp-ribose) synthetase inhibition prevents lipopolysaccharide-induced peroxynitrite mediated damage in diaphragm Pharmacol. Res. 46 2002 67 73
23. K. Plaschke, J. Kopitz, M.A. Weigand, E. Martin, and H.J. Bardenheuer The neuroprotective effect of cerebral poly(ADP-ribose)polymerase inhibition in a rat model of global ischemia Neurosci. Lett. 284 2000 109 112
24. V. Riley Psychoneuroendocrine influences on immunocompetence and neoplasia Science 212 1981 1100 1109
25. G.S. Scott, R.B. Kean, T. Mikheeva, M.J. Fabis, J.G. Mabley, C. Szabo, and D.C. Hooper The therapeutic effects of PJ34 [N-(6-oxo-5,6- dihydrophenanthridin-2-yl)-N,N-dimethylacetamide • HCl], a selective inhibitor of poly(ADP-ribose) polymerase, in experimental allergic encephalomyelitis are associated with immunomodulation J. Pharmacol. Exp. Ther. 310 2004 1053 1061
26. S.W. Suh, K. Aoyama, Y. Chen, P. Garnier, Y. Matsumori, E. Gum, J. Liu, and R.A. Swanson Hypoglycemic neuronal death and cognitive impairment are prevented by poly(ADP-ribose) polymerase inhibitors administered after hypoglycemia J. Neurosci. 23 2003 10681 10690
27. K. Takahashi, A.A. Pieper, S.E. Croul, J. Zhang, S.H. Snyder, and J.H. Greenberg Post-treatment with an inhibitor of poly(ADP-ribose) polymerase attenuates cerebral damage in focal ischemia Brain Res. 829 1999 46 54
28. S. Takasawa, and H. Okamoto Pancreatic beta-cell death, regeneration and insulin secretion: roles of poly(ADP-ribose) polymerase and cyclic ADP-ribose Int. J. Exp. Diabetes Res. 3 2002 79 96
29. J.N. Tournier, J. Mathieu, Y. Mailfert, E. Multon, C. Drouet, A. Jouan, and E. Drouet Chronic restraint stress induces severe disruption of the T-cell specific response to tetanus toxin vaccine Immunology 102 2001 87 93
30. B. Veres, F. Gallyas Jr., G. Varbiro, Z. Berente, E. Osz, G. Szekeres, C. Szabo, and B. Sumegi Decrease of the inflammatory response and induction of the Akt/protein kinase B pathway by poly-(ADP-ribose) polymerase 1 inhibitor in endotoxin-induced septic shock Biochem. Pharmacol. 65 2003 1373 1382
31. L. Virag, and C. Szabo The therapeutic potential of poly(ADP-ribose) polymerase inhibitors Pharmacol. Rev. 54 2002 375 429
32. E.V. Yang, and R. Glaser Stress-induced immunomodulation: impact on immune defenses against infectious disease Biomed. Pharmacother. 54 2000 245 250